Publications by authors named "Lucy Rowell"

Claim this Profile
P
Pharmacokinetic and Pharmacodynamic Analysis of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis From 2 Randomized, Controlled Trials: SUMMACTA and BREVACTA.
Hisham Abdallah, Joy C Hsu, Peng Lu, Scott Fettner, Xiaoping Zhang, Lucy Rowell

J Clin Pharmacol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial.
Joel M Kremer, Ricardo Blanco, Anne-Marie Halland, Marek Brzosko, Ruben Burgos-Vargas, Lucy Rowell

Clin Exp Rheumatol· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA).
Gerd R Burmester, Andrea Rubbert-Roth, Alain Cantagrel, Stephen Hall, Piotr Leszczynski, Lucy Rowell

Ann Rheum Dis· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous tocilizumab versus placebo in combination with disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
Alan Kivitz, Ewa Olech, Michael Borofsky, Beatriz M Zazueta, Federico Navarro-Sarabia, Lucy Rowell

Arthritis Care Res (Hoboken)· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study).
Gerd R Burmester, Andrea Rubbert-Roth, Alain Cantagrel, Stephen Hall, Piotr Leszczynski, Lucy Rowell

Ann Rheum Dis· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of disease-drug-drug interaction between single-dose tocilizumab and oral contraceptives in women with active rheumatoid arthritis.
Xiaoping Zhang, Lucy Rowell, Scott Fettner, Carol Lau, Denise Teuber

Int J Clin Pharmacol Ther· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of tocilizumab after subcutaneous administration in patients with rheumatoid arthritis.
Xiaoping Zhang, Ya-Chi Chen, Scott Fettner, Lucy Rowell, Tatiana Gott

Int J Clin Pharmacol Ther· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of single subcutaneous doses of tocilizumab administered with or without rHuPH20.
Peter N Morcos, Xiaoping Zhang, Christine McIntyre, Beate Bittner, Lucy Rowell

Int J Clin Pharmacol Ther· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, following single-dose administration by subcutaneous and intravenous routes to healthy subjects.
Xiaoping Zhang, Angela Georgy, Lucy Rowell

Int J Clin Pharmacol Ther· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of the tocilizumab in giant cell arteritis trial.
Sebastian H Unizony, Bhaskar Dasgupta, Elena Fisheleva, Lucy Rowell, Georg Schett

Int J Rheumatol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of hepatic and renal impairment on the pharmacokinetics of dalcetrapib: altered distribution of the active thiol?
Mary Phelan, Judith Anzures-Cabrera, David J Carlile, Lucy Rowell, Olaf Kuhlmann

Clin Pharmacokinet· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence of a drug-drug interaction linked to inhibition of ester hydrolysis by orlistat.
Darren Bentley, Anne-Marie Young, Lucy Rowell, Günter Gross, Joseph Tardio

J Cardiovasc Pharmacol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic interaction study of ritonavir-boosted saquinavir in combination with rifabutin in healthy subjects.
Xiaoping Zhang, Scott Fettner, Elke Zwanziger, Lucy Rowell, Miklos Salgo

Antimicrob Agents Chemother· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: the DIVA study.
Robert R Recker, Louis-George Ste-Marie, Bente Langdahl, Edward Czerwinski, Bernard Bonvoisin, Lucy Rowell

Bone· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from a toxicity-causing antiretroviral to enfuvirtide in patients with HIV: the SWITCH TOX study.
Adrian Streinu-Cercel, Miguel de Gorgolas, Markus Müller, Joaquin Portilla, Sorin Rugina, Lucy Rowell

HIV Clin Trials· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, controlled study evaluating an induction treatment strategy in which enfuvirtide was added to an oral, highly active antiretroviral therapy regimen in treatment-experienced patients: the INTENSE study.
Bonaventura Clotet, Amedeo Capetti, Luis E Soto-Ramirez, Jose M Gatell, Lucy Rowell

J Antimicrob Chemother· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of 48 weeks of enfuvirtide 180 mg once-daily dosing versus 90 mg twice-daily dosing in HIV-infected patients.
David Wright, Allen Rodriguez, Eliot Godofsky, Sharon Walmsley, Emily Labriola-Tompkins, Lucy Rowell

HIV Clin Trials· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enfuvirtide does not require dose adjustment in patients with chronic kidney failure: results of a pharmacokinetic study of enfuvirtide in HIV-1-infected patients with impaired kidney function.
Pablo Tebas, Nicholas Bellos, Christopher Lucasti, Gary Richmond, Eliot Godofsky, Lucy Rowell

J Acquir Immune Defic Syndr· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to enfuvirtide and its impact on treatment efficacy.
Jürgen Rockstroh, Edwin Dejesus, Lucille Donatacci, Cynthia Wat, Anne Bertasso, Lucy Rowell

AIDS Res Hum Retroviruses· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing proportional hazards and accelerated failure time models: an application in influenza.
Katie Patel, Richard Kay, Lucy Rowell

Pharm Stat· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of enfuvirtide for 48 weeks as part of an optimized antiretroviral regimen in pediatric human immunodeficiency virus 1-infected patients.
Andrew Wiznia, Joseph Church, Patricia Emmanuel, Stephen Eppes, Lucy Rowell

Pediatr Infect Dis J· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TORO: ninety-six-week virologic and immunologic response and safety evaluation of enfuvirtide with an optimized background of antiretrovirals.
Jacques Reynes, Keikawus Arastéh, Bonaventura Clotet, Calvin Cohen, David A Cooper, Lucy Rowell

AIDS Patient Care STDS· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lack of effect of moderate hepatic impairment on the pharmacokinetics of oral oseltamivir and its metabolite oseltamivir carboxylate.
Paul Snell, Nisha Dave, Katie Wilson, Lucy Rowell, Angelica Weil

Br J Clin Pharmacol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis